Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ASBP

Aspire Biopharma Holdings Inc

Feb 21 • 04:00PM ET

2.56

Dollar change -3.60
Percentage change -58.44	%

Financial • Shell Companies • USA • NASD

Held by: SPAX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	92.56%	Shs Outstand	7.77M	Perf Week	-81.73%
Market Cap	19.89M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.58M	Perf Month	-77.74%
Income	-3.76M	PEG	-	EPS next Q	-	Inst Own	6.00%	Short Float	-	Perf Quarter	-77.20%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-76.64%
Book/sh	0.01	P/B	220.12	EPS next Y	-	ROA	-28.30%	Short Interest	-	Perf Year	-75.64%
Cash/sh	0.00	P/C	-	EPS next 5Y	-	ROE	-38.21%	52W Range	4.80 - 15.80	Perf YTD	-77.74%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-4161.59%	52W High	-83.80%	Beta	0.05
Dividend TTM	-	Quick Ratio	0.01	Sales past 5Y	0.00%	Gross Margin	-	52W Low	-46.67%	ATR (14)	2.13
Dividend Ex-Date	Jul 14, 2005	Current Ratio	0.01	EPS Y/Y TTM	-325.44%	Oper. Margin	-	RSI (14)	24.84	Volatility	64.85% 23.30%
Employees	2	Debt/Eq	59.33	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / No	LT Debt/Eq	0.00	EPS Q/Q	-798.70%	Payout	0.00%	Rel Volume	92.14	Prev Close	6.16
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	14.94K	Price	2.56
SMA20	-76.59%	SMA50	-77.54%	SMA200	-77.15%	Trades		Volume	1,376,853	Change	-58.44%

Feb-20-25 06:15PM	Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement (ACCESSWIRE) -33.33% -58.44%
07:30AM	Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq (ACCESSWIRE)
Feb-19-25 01:10PM	Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq (ACCESSWIRE)
Sep-03-24 08:01AM	Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements (GlobeNewswire)
Jul-31-24 08:01AM	Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp. (GlobeNewswire)
04:05PM	Loading…
Jun-05-24 04:05PM	PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire)
May-20-24 05:11PM	PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders (GlobeNewswire)
May-16-24 04:05PM	PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders (GlobeNewswire) +7.62%
Jan-29-24 08:01AM	PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination (GlobeNewswire)
Dec-27-23 08:01AM	Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp. (GlobeNewswire)

Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engaged in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company was founded on February 2, 2025 and is headquartered in Humacao, Puerto Rico.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ASBP

Aspire Biopharma Holdings Inc

Upgrade your FINVIZ experience